Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Structural changes in valve prostheses].

M Minarini1, A F Maizza, G Thiene

  • 1Istituto di Anatomia Patologica, Università degli Studi, Padova.

Cardiologia (Rome, Italy)
|December 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful use of sirolimus in a patient with cardiac microangiopathy in primary antiphospholipid syndrome.

Scandinavian journal of rheumatology·2019
Same author

Letter to the Editor.

Journal of veterinary internal medicine·2017
Same author

Naturally Occurring Biventricular Noncompaction in an Adult Domestic Cat.

Journal of veterinary internal medicine·2017
Same author

Autopsy after transcatheter aortic valve implantation.

Virchows Archiv : an international journal of pathology·2017
Same author

Sudden cardiac arrest in sports - need for uniform registration: A Position Paper from the Sport Cardiology Section of the European Association for Cardiovascular Prevention and Rehabilitation.

European journal of preventive cardiology·2015
Same author

Arrhythmogenic right ventricular cardiomyopathy. Contribution of cardiac magnetic resonance imaging to the diagnosis.

Herz·2015
Same journal

[Prevention in coronary postangioplasty restenosis with omega-3 fatty acids. Results of the Italian study on prevention of restenosis with esapent (ESPRIT)].

Cardiologia (Rome, Italy)·2002
Same journal

[Results of GISSI Prevenzione: diet, drugs, and cardiovascular risk. Researchers of GISSI Prevenzione].

Cardiologia (Rome, Italy)·2002
Same journal

[New therapeutic strategies in heart failure. Which patients need defibrillation backup?].

Cardiologia (Rome, Italy)·2002
Same journal

[Electromechanical re-synchronization with sequential heart stimulation as a new non-pharmacologic treatment of advanced heart failure. Physiopathologic features and clinical results].

Cardiologia (Rome, Italy)·2002
Same journal

[New therapeutic strategies in heart failure. Pharmacologic therapy].

Cardiologia (Rome, Italy)·2002
Same journal

[Genetics as a guide for antihypertensive therapy: future perspectives].

Cardiologia (Rome, Italy)·2002
See all related articles

Both mechanical and biological heart valve prostheses face structural complications, leading to reoperation or death. Understanding these risks is crucial for patient outcomes and prosthesis selection.

Area of Science:

  • Cardiovascular Surgery
  • Biomaterials Science
  • Medical Device Engineering

Background:

  • Heart valve prostheses, both mechanical and biological, are susceptible to structural alterations.
  • These alterations can lead to reoperation or mortality.
  • Complications can be common to all valve types or specific to certain models.

Purpose of the Study:

  • To review the structural complications associated with mechanical and biological heart valve prostheses.
  • To differentiate between common and model-specific complications.
  • To inform clinical decision-making regarding prosthesis choice and management.

Main Methods:

  • Literature review of prosthetic heart valve complications.
  • Analysis of structural deterioration patterns in mechanical and biological valves.

Related Experiment Videos

  • Categorization of complications based on prosthesis type and specific models.

    • Main Results:

    • Mechanical prostheses are durable but thrombogenic, necessitating anticoagulation with associated hemorrhage risks.
    • Bioprostheses have lower thrombogenicity but undergo structural degeneration (e.g., calcification), often requiring reoperation within 8-10 years.
    • Infective endocarditis and fibrous tissue overgrowth affect both types of prostheses.

    Conclusions:

    • Both mechanical and biological prostheses have inherent risks requiring careful consideration.
    • The choice between mechanical and biological valves involves balancing thrombogenicity against structural durability.
    • Long-term monitoring is essential for managing complications in all prosthetic heart valves.